Glucocorticoids inhibit the bradykinin B2 receptor increase induced by interleukin-1β in human bronchial smooth muscle cells

European Journal of Pharmacology

Volumn 354, Issue 1, 1998, Pages

  Schmidlin, Fabien ^a   Scherrer, Didier ^a   Landry, Yves ^a   Gies, Jean Pierre ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Asthma; Glucocorticoid; Hyperreactivity

Indexed keywords

BRADYKININ B2 RECEPTOR; BUDESONIDE; CYCLOHEXIMIDE; DEXAMETHASONE; GLUCOCORTICOID; INOSITOL PHOSPHATE; INTERLEUKIN 1BETA; MESSENGER RNA;

ARTICLE; BRONCHUS HYPERREACTIVITY; BRONCHUS MUSCLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANTI-INFLAMMATORY AGENTS; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; BUDESONIDE; CELLS, CULTURED; DEXAMETHASONE; DRUG INTERACTIONS; HUMANS; INOSITOL PHOSPHATES; INTERLEUKIN-1; MUSCLE, SMOOTH; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RNA, MESSENGER;

EID: 0031709993     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00478-6     Document Type: Article

References (6)

1. Church, M.K., Holgate, S.T., 1986. Adenosine and asthma. Trends Pharmacol. Sci. 7, 49-50.
2. De Bie, J.J., Hessel, E.M., Van Ark, I., Van Esch, B., Hofman, G., Nijkamp, F.P., Van Oosterhout, A.J., 1996. Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br. J. Pharmacol. 119, 1484-1490.
3. Fuller, R.W., Dixon, C.M.S., Cuss, F.M.C., Barnes, P.J., 1987. Bradykinin induced bronchoconstriction in humans. Am. Rev. Respir. Dis. 135, 176-180.
4. Kraan, J., Koeter, G.H., Van Der Mark, T.H.W., Boorsma, M., Kukler, J., Sluiter, H.J., De Vries, K., 1988. Dosage and time effects of inhalated budesonide on bronchial hyperreactivity. Am. Rev. Respir. Dis. 137, 44-48.
5. Lee, T.H., 1992. Precipitating factors of asthma. Br. Med. Bull. 48, 169-178.
6. Schmidlin, F., Scherrer, D., Daeffler, L., Bertrand, C., Landry, Y., Gies, J.-P., 1998. Interleukin-1β induces bradykinin B2 receptor gene expression through a prostanoid cAMP-dependent pathway in human bronchial smooth muscle cells. Mol. Pharmacol. 53, 1009-1015.